Bridget E. Bunner

Array ( [id] => 5754677 [patent_doc_number] => 20060223826 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-05 [patent_title] => 'Indole derivatives as somatostatin agonists or antagonists' [patent_app_type] => utility [patent_app_number] => 10/534725 [patent_app_country] => US [patent_app_date] => 2003-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 98787 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0223/20060223826.pdf [firstpage_image] =>[orig_patent_app_number] => 10534725 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5769280 [patent_doc_number] => 20060019959 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-26 [patent_title] => 'Novel quinoxalinone derivatives' [patent_app_type] => utility [patent_app_number] => 10/532677 [patent_app_country] => US [patent_app_date] => 2003-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 57687 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20060019959.pdf [firstpage_image] =>[orig_patent_app_number] => 10532677 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5711252 [patent_doc_number] => 20060052597 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-09 [patent_title] => 'Aryloxyalkylamine derivatives as h3 receptor ligands' [patent_app_type] => utility [patent_app_number] => 10/532371 [patent_app_country] => US [patent_app_date] => 2003-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17210 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20060052597.pdf [firstpage_image] =>[orig_patent_app_number] => 10532371 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7388079 [patent_doc_number] => 20040082786 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-29 [patent_title] => 'Piperazine based inhibitors of factor xa' [patent_app_type] => new [patent_app_number] => 10/381928 [patent_app_country] => US [patent_app_date] => 2003-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15981 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20040082786.pdf [firstpage_image] =>[orig_patent_app_number] => 10381928 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5875327 [patent_doc_number] => 20060167008 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-27 [patent_title] => 'Substituted 1,4,-di-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists' [patent_app_type] => utility [patent_app_number] => 10/527821 [patent_app_country] => US [patent_app_date] => 2003-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17809 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20060167008.pdf [firstpage_image] =>[orig_patent_app_number] => 10527821 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5777390 [patent_doc_number] => 20060106030 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-18 [patent_title] => 'Structurally rigid dopamine d3 receptor selective ligands and process for making them' [patent_app_type] => utility [patent_app_number] => 10/527594 [patent_app_country] => US [patent_app_date] => 2003-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6415 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20060106030.pdf [firstpage_image] =>[orig_patent_app_number] => 10527594 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7468555 [patent_doc_number] => 20040053966 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-18 [patent_title] => 'Chemical derivatives and their application as antitelomerase agent' [patent_app_type] => new [patent_app_number] => 10/658394 [patent_app_country] => US [patent_app_date] => 2003-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11413 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20040053966.pdf [firstpage_image] =>[orig_patent_app_number] => 10658394 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6906221 [patent_doc_number] => 20050101616 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-12 [patent_title] => 'Quinazoline analogs as receptor tyrosine kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 10/642440 [patent_app_country] => US [patent_app_date] => 2003-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 16240 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20050101616.pdf [firstpage_image] =>[orig_patent_app_number] => 10642440 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5733454 [patent_doc_number] => 20060258571 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-16 [patent_title] => 'Antibacterial ester macrocycles' [patent_app_type] => utility [patent_app_number] => 10/522667 [patent_app_country] => US [patent_app_date] => 2003-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23612 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20060258571.pdf [firstpage_image] =>[orig_patent_app_number] => 10522667 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7450433 [patent_doc_number] => 20040010033 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-15 [patent_title] => 'Non-peptide GnRH agents, methods and intermediates for their preparation' [patent_app_type] => new [patent_app_number] => 10/353160 [patent_app_country] => US [patent_app_date] => 2003-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13480 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20040010033.pdf [firstpage_image] =>[orig_patent_app_number] => 10353160 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 860792 [patent_doc_number] => 07371872 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-05-13 [patent_title] => 'Prodrugs of excitatory amino acids' [patent_app_type] => utility [patent_app_number] => 10/516559 [patent_app_country] => US [patent_app_date] => 2003-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 48906 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/371/07371872.pdf [firstpage_image] =>[orig_patent_app_number] => 10516559 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 556448 [patent_doc_number] => 07468368 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-12-23 [patent_title] => 'Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof' [patent_app_type] => utility [patent_app_number] => 10/516704 [patent_app_country] => US [patent_app_date] => 2003-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26194 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/468/07468368.pdf [firstpage_image] =>[orig_patent_app_number] => 10516704 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5739092 [patent_doc_number] => 20060009483 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-12 [patent_title] => 'Compounds and compositions for the treatment of diabetes and diabetes-related disorders' [patent_app_type] => utility [patent_app_number] => 10/506230 [patent_app_country] => US [patent_app_date] => 2003-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13695 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20060009483.pdf [firstpage_image] =>[orig_patent_app_number] => 10506230 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 112316 [patent_doc_number] => 07718792 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-18 [patent_title] => 'Stereospecific reduction of sapogen-3-ones' [patent_app_type] => utility [patent_app_number] => 10/531086 [patent_app_country] => US [patent_app_date] => 2003-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7736 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/718/07718792.pdf [firstpage_image] =>[orig_patent_app_number] => 10531086 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 285534 [patent_doc_number] => 07550461 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-23 [patent_title] => 'Benzofuran and benzothiophene compounds useful in treating cytokine mediated diseases' [patent_app_type] => utility [patent_app_number] => 10/410688 [patent_app_country] => US [patent_app_date] => 2003-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14999 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/550/07550461.pdf [firstpage_image] =>[orig_patent_app_number] => 10410688 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6952893 [patent_doc_number] => 20050227988 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-13 [patent_title] => 'Tyrosine kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 10/510610 [patent_app_country] => US [patent_app_date] => 2003-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18872 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20050227988.pdf [firstpage_image] =>[orig_patent_app_number] => 10510610 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 589345 [patent_doc_number] => 07439362 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-10-21 [patent_title] => 'Piperazinyl-or piperidinylamine-sulfamic acid amides as inhibitors of steroid sulfatase' [patent_app_type] => utility [patent_app_number] => 10/509259 [patent_app_country] => US [patent_app_date] => 2003-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6380 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/439/07439362.pdf [firstpage_image] =>[orig_patent_app_number] => 10509259 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5859909 [patent_doc_number] => 20060229316 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-12 [patent_title] => 'Novel antiinfective compounds, process for their preparation and pharmaceutical compositions containing them' [patent_app_type] => utility [patent_app_number] => 10/509892 [patent_app_country] => US [patent_app_date] => 2003-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23224 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20060229316.pdf [firstpage_image] =>[orig_patent_app_number] => 10509892 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7188083 [patent_doc_number] => 20050192273 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-01 [patent_title] => 'Therapy for psychoses combining an atypical antipsychotic and an mglu2/3 receptor agonist' [patent_app_type] => utility [patent_app_number] => 10/509772 [patent_app_country] => US [patent_app_date] => 2003-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7455 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20050192273.pdf [firstpage_image] =>[orig_patent_app_number] => 10509772 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 54059 [patent_doc_number] => 07767659 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-03 [patent_title] => 'Synthesis of naturally occurring ecteinascidins and related compounds' [patent_app_type] => utility [patent_app_number] => 10/503106 [patent_app_country] => US [patent_app_date] => 2003-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42606 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/767/07767659.pdf [firstpage_image] =>[orig_patent_app_number] => 10503106 [rel_patent_id] =>[rel_patent_doc_number] =>)